Targeting protein modification: a new direction for immunotherapy of pancreatic cancer

被引:0
|
作者
Ge, Xinyu [1 ]
Zhang, Ke [2 ]
Zhu, Jie [1 ]
Chen, Yuan [1 ]
Wang, Zhengwang [1 ]
Wang, Peng [1 ]
Xu, Peng [1 ]
Yao, Jie [1 ]
机构
[1] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Yangzhou 225000, Jiangsu, Peoples R China
[2] Dalian Med Univ, Yangzhou Sch Clin Med, Yangzhou 225000, Jiangsu, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Post-translational modifications; Immunotherapy; Targeted therapy; Immune escape; Pancreatic cancer; PD-L1; EXPRESSION; AUGMENTS IMMUNOTHERAPY; ACTIVATION; INHIBITION; PHOSPHORYLATION; GLYCOSYLATION; PATHWAY; GROWTH; CELLS; SUMO;
D O I
10.7150/ijbs.101861
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Post-translational modifications (PTMs) alter protein conformation by covalently attaching functional groups to substrates, influencing their biological activity, mechanisms of action, and functional performance. PTMs and their interactions are essential to many critical signal transduction processes, including tumor transformation, cancer progression, and metastasis in pancreatic cancer. Additionally, advancements in tumor immunotherapy indicate that PTMs are essential in immune cell activation, transport, and energy metabolism. This study aimed to investigate the effects of different PTMs on immunotherapy for pancreatic cancer, providing new perspectives and suggesting directions for future research.
引用
收藏
页码:63 / 74
页数:12
相关论文
共 50 条
  • [1] Immunotherapy synergizes with chemotherapy targeting pancreatic cancer
    Koido, Shigeo
    Homma, Sadamu
    Takahara, Akitaka
    Namiki, Yoshihisa
    Komita, Hideo
    Uchiyama, Kan
    Ito, Masaki
    Gong, Jianlin
    Ohkusa, Toshifumi
    Tajiri, Hisao
    IMMUNOTHERAPY, 2012, 4 (01) : 5 - 7
  • [2] Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?
    Storz, Peter
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (05) : 501 - 504
  • [3] Targeting ATM to sensitize pancreatic cancer to immunotherapy and radiotherapy
    Green, Michael
    Zhang, Qiang
    Lang, Xueting
    Lei, Yu
    Lawrence, Theodore S.
    Zou, Weiping
    Morgan, Meredith A.
    CANCER RESEARCH, 2019, 79 (24)
  • [4] Peptide drugs: a new direction in cancer immunotherapy
    Xinghua Sui
    Xiaoshuang Niu
    Xiuman Zhou
    Yanfeng Gao
    Cancer Biology & Medicine, 2024, 21 (03) : 198 - 203
  • [5] Peptide drugs: a new direction in cancer immunotherapy
    Sui, Xinghua
    Niu, Xiaoshuang
    Zhou, Xiuman
    Gao, Yanfeng
    CANCER BIOLOGY & MEDICINE, 2024, 21 (03) : 198 - 203
  • [6] Pancreatic Cancer: New Approach for Immunotherapy
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (08): : 726 - +
  • [7] Targeting protein kinases benefits cancer immunotherapy
    Zhang, Zhengkun
    Bu, Lang
    Luo, Junhang
    Guo, Jianping
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2022, 1877 (04):
  • [8] Targeting the RNA m6A modification for cancer immunotherapy
    Li, Xinxin
    Ma, Shoubao
    Deng, Youcai
    Yi, Ping
    Yu, Jianhua
    MOLECULAR CANCER, 2022, 21 (01)
  • [9] Targeting the RNA m6A modification for cancer immunotherapy
    Xinxin Li
    Shoubao Ma
    Youcai Deng
    Ping Yi
    Jianhua Yu
    Molecular Cancer, 21
  • [10] TARGETING THE CD200 CHECKPOINT BLOCKADE: A NEW DIRECTION FOR IMMUNOTHERAPY
    Olin, Michael
    Ampudia-Mesias, Elisabet
    Xiong, Zhengming
    Pluhar, Elizabeth
    Moertel, Christopher
    NEURO-ONCOLOGY, 2017, 19 : 114 - 115